Skip to content
Advanced Technology International
  • Who We Serve
    • Government Agencies
    • Innovators
  • R&D Opportunities
    • Active & Upcoming Opportunities
    • Project Awards
  • Join a Collaboration
    • Search Tool
    • Portfolio
  • OTA
  • About
    • Who We Are
    • Leadership
    • TechConnect
    • ATI Foundation
    • Corporate Impact
    • Contact Us
  • News & Events
    • News
    • Events
  • Careers
  • Centivax and U.S. Naval Medical Research Center announce strategic partnership to initiate clinical development of a broad-spectrum injectable for COVID-19, with $4.2M from the Henry Jackson Foundation

    0 words0 min read

    "With discovery research supported by Medical Technology Enterprise Consortium, and now clinical development supported by our remarkable collaboration with the Naval Medical Research Center, this biotech-government partnership is proud to advance this molecule into clinical development and closer to the patients and doctors that need a better medicine to end the pandemic."

    Read More
Previous414243Next

About Us

  • Leadership
  • ATI Foundation
  • Careers
  • News

Who We Serve

  • Government Agencies
  • Innovators

Get Engaged

  • Active and Upcoming R&D Opportunities
  • Portfolio
  • Doing Business with ATI
  • CMMC Resources
  • ATI & Collaboration Events

CONTACT US

315 Sigma Drive
Summerville, SC 29486
Email: info@ati.org

Advanced Technology International

© Copyright 2012 - 2026 | Advanced Technology International

ATI

Privacy & Terms of Use | Accessibility | Site Map

Page load link
Go to Top